Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.

Saved in:
Bibliographic Details
Title: Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.
Authors: Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Rosenberger CL; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Moore N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Foster JC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Naqash AR; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Sharon E; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., O'Sullivan Coyne G; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Schwartz GK; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH., Riedel RF; Duke Cancer Institute, Duke University Medical Center, Durham, NC., Glod J; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Hu JS; Division of Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA., Conley AP; The University of Texas MD Anderson Cancer Center, Houston, TX., Read WL; Emory University, Atlanta, GA., Burgess MA; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA., Davis EJ; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Merriam P; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Deshpande HA; Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT., Ladle BH; Department of Oncology, Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD., Okuno SH; Mayo Clinic, Rochester, MN., Beck JC; Division of Pediatric Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE., Chen JL; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Ferry-Galow KV; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD., Fino KK; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD., Miller BL; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD., Wilsker DF; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD., Begum A; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD., Parchment RE; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jun; Vol. 44 (16), pp. 1490-1497. Date of Electronic Publication: 2026 Apr 18.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41999612
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chen+AP%22">Chen AP</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Rosenberger+CL%22">Rosenberger CL</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Moore+N%22">Moore N</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Foster+JC%22">Foster JC</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Naqash+AR%22">Naqash AR</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Sharon+E%22">Sharon E</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22O'Sullivan+Coyne+G%22">O'Sullivan Coyne G</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Schwartz+GK%22">Schwartz GK</searchLink>; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Riedel+RF%22">Riedel RF</searchLink>; Duke Cancer Institute, Duke University Medical Center, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Glod+J%22">Glod J</searchLink>; Center for Cancer Research, National Cancer Institute, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Hu+JS%22">Hu JS</searchLink>; Division of Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Conley+AP%22">Conley AP</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Read+WL%22">Read WL</searchLink>; Emory University, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Burgess+MA%22">Burgess MA</searchLink>; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA.<br /><searchLink fieldCode="AU" term="%22Davis+EJ%22">Davis EJ</searchLink>; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.<br /><searchLink fieldCode="AU" term="%22Merriam+P%22">Merriam P</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Deshpande+HA%22">Deshpande HA</searchLink>; Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Ladle+BH%22">Ladle BH</searchLink>; Department of Oncology, Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Okuno+SH%22">Okuno SH</searchLink>; Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Beck+JC%22">Beck JC</searchLink>; Division of Pediatric Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE.<br /><searchLink fieldCode="AU" term="%22Chen+JL%22">Chen JL</searchLink>; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Ferry-Galow+KV%22">Ferry-Galow KV</searchLink>; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.<br /><searchLink fieldCode="AU" term="%22Fino+KK%22">Fino KK</searchLink>; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.<br /><searchLink fieldCode="AU" term="%22Miller+BL%22">Miller BL</searchLink>; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.<br /><searchLink fieldCode="AU" term="%22Wilsker+DF%22">Wilsker DF</searchLink>; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.<br /><searchLink fieldCode="AU" term="%22Begum+A%22">Begum A</searchLink>; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.<br /><searchLink fieldCode="AU" term="%22Parchment+RE%22">Parchment RE</searchLink>; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.<br /><searchLink fieldCode="AU" term="%22Doroshow+JH%22">Doroshow JH</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Center for Cancer Research, National Cancer Institute, Bethesda, MD.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2026 Jun; Vol. 44 (16), pp. 1490-1497. <i>Date of Electronic Publication: </i>2026 Apr 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41999612
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO-25-02811
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1490
    Titles:
      – TitleFull: Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chen AP
      – PersonEntity:
          Name:
            NameFull: Rosenberger CL
      – PersonEntity:
          Name:
            NameFull: Moore N
      – PersonEntity:
          Name:
            NameFull: Foster JC
      – PersonEntity:
          Name:
            NameFull: Naqash AR
      – PersonEntity:
          Name:
            NameFull: Sharon E
      – PersonEntity:
          Name:
            NameFull: O'Sullivan Coyne G
      – PersonEntity:
          Name:
            NameFull: Schwartz GK
      – PersonEntity:
          Name:
            NameFull: Riedel RF
      – PersonEntity:
          Name:
            NameFull: Glod J
      – PersonEntity:
          Name:
            NameFull: Hu JS
      – PersonEntity:
          Name:
            NameFull: Conley AP
      – PersonEntity:
          Name:
            NameFull: Read WL
      – PersonEntity:
          Name:
            NameFull: Burgess MA
      – PersonEntity:
          Name:
            NameFull: Davis EJ
      – PersonEntity:
          Name:
            NameFull: Merriam P
      – PersonEntity:
          Name:
            NameFull: Deshpande HA
      – PersonEntity:
          Name:
            NameFull: Ladle BH
      – PersonEntity:
          Name:
            NameFull: Okuno SH
      – PersonEntity:
          Name:
            NameFull: Beck JC
      – PersonEntity:
          Name:
            NameFull: Chen JL
      – PersonEntity:
          Name:
            NameFull: Ferry-Galow KV
      – PersonEntity:
          Name:
            NameFull: Fino KK
      – PersonEntity:
          Name:
            NameFull: Miller BL
      – PersonEntity:
          Name:
            NameFull: Wilsker DF
      – PersonEntity:
          Name:
            NameFull: Begum A
      – PersonEntity:
          Name:
            NameFull: Parchment RE
      – PersonEntity:
          Name:
            NameFull: Doroshow JH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 16
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1